Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura

PHASE3CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

March 31, 2008

Conditions
Migraine With Aura
Interventions
DEVICE

Active Transcranial Magnetic Stimulation (TMS) Device

Transcranial Magnetic Stimulation Device treatment

DEVICE

Sham TMS Device

Simulated Sham treatment without TMS delivery

Trial Locations (14)

10461

Montefiore Headache Center, The Bronx

19107

Jefferson Headache Center, Philadelphia

22304

The Innovative Clinical Research Center, Alexandria

37203

Nashville Neuroscience Group, Nashville

43210

The Ohio State University, Columbus

48104

Michigan Head Pain & Neurological Institute, Ann Arbor

49009

Westside Family Medical Center, Kalamazoo

60614

Diamond Headache Clinic, LTD, Chicago

63141

Mercy Health Research, St Louis

65807

Clinvest, Inc., Springfield

68144

Kirchner Headache Clinic, Omaha

80218

Mile High Research Center, Denver

94109

San Francisco Headache Clinic, San Francisco

98104

Swedish Headache Center, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Neuralieve

INDUSTRY

NCT00449540 - Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura | Biotech Hunter | Biotech Hunter